Pilot Study of Simtuzumab in the Treatment of Liver Fibrosis

NCT01452308 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Gilead Sciences